Harrow Health Inc (NASDAQ:HROW)

6.11
Delayed Data
As of May 17
 +0.25 / +4.27%
Today’s Change
1.99
Today|||52-Week Range
7.20
+7.38%
Year-to-Date
No recent news for Harrow Health Inc.

Today’s Trading

Previous close5.86
Today’s open6.43
Day’s range5.88 - 6.70
Volume1,078,519
Average volume (3 months)244,904
Market cap$156.0M
Data as of 3:59pm ET, 05/17/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-84.43%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+54.52%
P/E ratio5.0
Price/Sales3.27
Price/Book6.21

Competitors

 Today’s
change
Today’s
% change
TYMETyme Technologies In...-0.05-3.31%
OCULOcular Therapeutix I...-0.07-1.98%
FOMXFoamix Pharmaceutica...+0.06+2.26%
PRTKParatek Pharmaceutic...+0.03+0.66%
Data as of 4:00pm ET, 05/17/2019

Financials

Next reporting dateAugust 14, 2019
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$41.4M
Annual profit (last year)$14.6M
Net profit margin35.35%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
CFO, Secretary &
Principal Accounting Officer
Andrew R. Boll
Corporate headquarters
San Diego, California

Forecasts